Bao Beier, He Yingzi, Tang Dongmei, Li Wenyan, Li Huawei
State Key Laboratory of Medical Neurobiology, Medical College of Fudan University Shanghai, China.
ENT Institute and Otorhinolaryngology Department of Affiliated Eye and ENT Hospital, State Key Laboratory of Medical Neurobiology, Fudan UniversityShanghai, China; Key Laboratory of Hearing Medicine of National Health and Family Planning CommissionShanghai, China.
Front Mol Neurosci. 2017 Mar 13;10:51. doi: 10.3389/fnmol.2017.00051. eCollection 2017.
The H3K27 demethylases are involved in a variety of biological processes, including cell differentiation, proliferation, and cell death by regulating transcriptional activity. However, the function of H3K27 demethylation in the field of hearing research is poorly understood. Here, we investigated the role of H3K27me3 histone demethylase activity in hair cell regeneration using an animal model. Our data showed that pharmacologic inhibition of H3K27 demethylase activity with the specific small-molecule inhibitor GSK-J4 decreased the number of regenerated hair cells in response to neomycin damage. Furthermore, inhibition of H3K27me3 histone demethylase activity dramatically suppressed cell proliferation and activated caspase-3 levels in the regenerating neuromasts of the zebrafish lateral line. GSK-J4 administration also increased the expression of and in neuromast cells and inhibited the ERK signaling pathway. Collectively, our findings indicate that H3K27me3 demethylation is a key epigenetic regulator in the process of hair cell regeneration in zebrafish and suggest that H3K27me3 histone demethylase activity might be a novel therapeutic target for the treatment of hearing loss.
H3K27去甲基化酶通过调节转录活性参与多种生物学过程,包括细胞分化、增殖和细胞死亡。然而,H3K27去甲基化在听力研究领域的功能仍知之甚少。在此,我们使用动物模型研究了H3K27me3组蛋白去甲基化酶活性在毛细胞再生中的作用。我们的数据表明,用特异性小分子抑制剂GSK-J4对H3K27去甲基化酶活性进行药理抑制,会减少新霉素损伤后再生毛细胞的数量。此外,抑制H3K27me3组蛋白去甲基化酶活性显著抑制了斑马鱼侧线再生神经丘中的细胞增殖并激活了caspase-3水平。给予GSK-J4还增加了神经丘细胞中 和 的表达,并抑制了ERK信号通路。总的来说,我们的研究结果表明,H3K27me3去甲基化是斑马鱼毛细胞再生过程中的关键表观遗传调节因子,并表明H3K27me3组蛋白去甲基化酶活性可能是治疗听力损失的新治疗靶点。